These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 36113719)
1. Reply to: "Response to: A randomized-controlled trial comparing 20% albumin to plasmalyte in patients with cirrhosis and sepsis-induced hypotension [ALPS trial]". Maiwall R; Deshmukh A; Sarin SK J Hepatol; 2022 Dec; 77(6):1732-1733. PubMed ID: 36113719 [No Abstract] [Full Text] [Related]
2. Response to: A randomized-controlled trial comparing 20% albumin to plasmalyte in patients with cirrhosis and sepsis-induced hypotension [ALPS trial]. Maimone S; Tripodi VF; Mazzeo AT J Hepatol; 2022 Dec; 77(6):1731-1732. PubMed ID: 35810928 [No Abstract] [Full Text] [Related]
3. A randomized-controlled trial comparing 20% albumin to plasmalyte in patients with cirrhosis and sepsis-induced hypotension [ALPS trial]. Maiwall R; Kumar A; Pasupuleti SSR; Hidam AK; Tevethia H; Kumar G; Sahney A; Mitra LG; Sarin SK J Hepatol; 2022 Sep; 77(3):670-682. PubMed ID: 35460725 [TBL] [Abstract][Full Text] [Related]
4. Comparison of 5% human albumin and normal saline for fluid resuscitation in sepsis induced hypotension among patients with cirrhosis (FRISC study): a randomized controlled trial. Philips CA; Maiwall R; Sharma MK; Jindal A; Choudhury AK; Kumar G; Bhardwaj A; Mitra LG; Agarwal PM; Sarin SK Hepatol Int; 2021 Aug; 15(4):983-994. PubMed ID: 34036519 [TBL] [Abstract][Full Text] [Related]
5. Reply to "Albumin infusion in cirrhotic patients with non-SBP infections: End of the story?". Thevenot T; Monnet E; di Martino V; J Hepatol; 2015 Sep; 63(3):768-9. PubMed ID: 25998162 [No Abstract] [Full Text] [Related]
6. Albumin infusion may deleteriously promote extracellular fluid overload without improving circulating hypovolemia in patients of advanced cirrhosis with diabetes mellitus and sepsis. Kumar R; Kumar S; Lata S Med Hypotheses; 2013 Apr; 80(4):452-5. PubMed ID: 23375411 [TBL] [Abstract][Full Text] [Related]
7. Role of albumin in diseases associated with severe systemic inflammation: Pathophysiologic and clinical evidence in sepsis and in decompensated cirrhosis. Artigas A; Wernerman J; Arroyo V; Vincent JL; Levy M J Crit Care; 2016 Jun; 33():62-70. PubMed ID: 26831575 [TBL] [Abstract][Full Text] [Related]
8. Midodrine and albumin for prevention of complications in patients with cirrhosis awaiting liver transplantation. A randomized placebo-controlled trial. Solà E; Solé C; Simón-Talero M; Martín-Llahí M; Castellote J; Garcia-Martínez R; Moreira R; Torrens M; Márquez F; Fabrellas N; de Prada G; Huelin P; Lopez Benaiges E; Ventura M; Manríquez M; Nazar A; Ariza X; Suñé P; Graupera I; Pose E; Colmenero J; Pavesi M; Guevara M; Navasa M; Xiol X; Córdoba J; Vargas V; Ginès P J Hepatol; 2018 Dec; 69(6):1250-1259. PubMed ID: 30138685 [TBL] [Abstract][Full Text] [Related]
9. Effect of albumin in cirrhotic patients with infection other than spontaneous bacterial peritonitis. A randomized trial. Thévenot T; Bureau C; Oberti F; Anty R; Louvet A; Plessier A; Rudler M; Heurgué-Berlot A; Rosa I; Talbodec N; Dao T; Ozenne V; Carbonell N; Causse X; Goria O; Minello A; De Ledinghen V; Amathieu R; Barraud H; Nguyen-Khac E; Becker C; Paupard T; Botta-Fridlung D; Abdelli N; Guillemot F; Monnet E; Di Martino V J Hepatol; 2015 Apr; 62(4):822-30. PubMed ID: 25463545 [TBL] [Abstract][Full Text] [Related]
10. Albumin infusion in cirrhotic patients with infections other than spontaneous bacterial peritonitis: End of the story? Merli M; Lucidi C; Lattanzi B; Riggio O J Hepatol; 2015 Sep; 63(3):767-8. PubMed ID: 25988298 [No Abstract] [Full Text] [Related]
11. Safe use of induced hypotension in a patient with cirrhotic liver disease. Roth S; Run S Can J Anaesth; 1987 Mar; 34(2):186-9. PubMed ID: 3829308 [TBL] [Abstract][Full Text] [Related]
12. ATTIRE: Albumin To prevenT Infection in chronic liveR failurE: study protocol for a single-arm feasibility trial. China L; Muirhead N; Skene SS; Shabir Z; De Maeyer RP; Maini A; Gilroy DW; O'Brien AJ BMJ Open; 2016 Jan; 6(1):e010132. PubMed ID: 26810999 [TBL] [Abstract][Full Text] [Related]
13. Sepsis and cirrhosis: many similarities. Vincent JL; Gustot T Acta Gastroenterol Belg; 2010; 73(4):472-8. PubMed ID: 21299157 [TBL] [Abstract][Full Text] [Related]
14. Long-term albumin administration in patients with cirrhosis and ascites: A meta-analysis of randomized controlled trials. Sandi BB; Leão GS; de Mattos AA; de Mattos ÂZ J Gastroenterol Hepatol; 2021 Mar; 36(3):609-617. PubMed ID: 32914468 [TBL] [Abstract][Full Text] [Related]
15. Management of Sepsis in Patients With Cirrhosis: Current Evidence and Practical Approach. Simonetto DA; Piccolo Serafim L; Gallo de Moraes A; Gajic O; Kamath PS Hepatology; 2019 Jul; 70(1):418-428. PubMed ID: 30516866 [TBL] [Abstract][Full Text] [Related]
16. Assessment of INR to Albumin Ratio in Predicting Outcome During Hospital Stay in Patients with Cirrhosis of Liver with Sepsis. S S J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443527 [TBL] [Abstract][Full Text] [Related]
17. Targeted Albumin Therapy Does Not Improve Short-Term Outcome in Hyponatremic Patients Hospitalized With Complications of Cirrhosis: Data From the ATTIRE Trial. China L; Freemantle N; Forrest E; Kallis Y; Ryder SD; Wright G; O'Brien A Am J Gastroenterol; 2021 Nov; 116(11):2292-2295. PubMed ID: 34520431 [TBL] [Abstract][Full Text] [Related]
18. A Randomized Trial of Albumin Infusions in Hospitalized Patients with Cirrhosis. China L; Freemantle N; Forrest E; Kallis Y; Ryder SD; Wright G; Portal AJ; Becares Salles N; Gilroy DW; O'Brien A; N Engl J Med; 2021 Mar; 384(9):808-817. PubMed ID: 33657293 [TBL] [Abstract][Full Text] [Related]
19. Reply to: "Effect of albumin on survival in septic cirrhotic patients other than spontaneous bacterial peritonitis. The question remains open". Guevara M; Arroyo V; Ginès P J Hepatol; 2013 Mar; 58(3):640. PubMed ID: 23220371 [No Abstract] [Full Text] [Related]
20. Effects of Albumin Treatment on Systemic and Portal Hemodynamics and Systemic Inflammation in Patients With Decompensated Cirrhosis. Fernández J; Clària J; Amorós A; Aguilar F; Castro M; Casulleras M; Acevedo J; Duran-Güell M; Nuñez L; Costa M; Torres M; Horrillo R; Ruiz-Del-Árbol L; Villanueva C; Prado V; Arteaga M; Trebicka J; Angeli P; Merli M; Alessandria C; Aagaard NK; Soriano G; Durand F; Gerbes A; Gustot T; Welzel TM; Salerno F; Bañares R; Vargas V; Albillos A; Silva A; Morales-Ruiz M; Carlos García-Pagán J; Pavesi M; Jalan R; Bernardi M; Moreau R; Páez A; Arroyo V Gastroenterology; 2019 Jul; 157(1):149-162. PubMed ID: 30905652 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]